EAST RUTHERFORD, N.J., April 23, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback